Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates von BRAHMER, Julie R, DRAKE, Charles G, GILSON, Marta M, CHANGYU WANG, SELBY, Mark, TAUBE, Janis M, ANDERS, Robert, LIEPING CHEN, KORMAN, Alan J, PARDOLL, Drew M, LOWY, Israel, TOPALIAN, Suzanne L, WOLLNER, Ira, POWDERLY, John D, PICUS, Joel, SHARFMAN, William H, STANKEVICH, Elizabeth, PONS, Alice, SALAY, Theresa M, MCMILLER, Tracee L

Volltext

Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates von Brahmer, Julie R, Drake, Charles G, Wollner, Ira, Powderly, John D, Picus, Joel, Sharfman, William H, Stankevich, Elizabeth, Pons, Alice, Salay, Theresa M, McMiller, Tracee L, Gilson, Marta M, Wang, Changyu, Selby, Mark, Taube, Janis M, Anders, Robert, Chen, Lieping, Korman, Alan J, Pardoll, Drew M, Lowy, Israel, Topalian, Suzanne L

Volltext

Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy von Depontieu, Florence R, Qian, Jie, Zarling, Angela L, McMiller, Tracee L, Salay, Theresa M, Norris, Andrew, English, A. Michelle, Shabanowitz, Jeffrey, Engelhard, Victor H, Hunt, Donald F, Topalian, Suzanne L

Volltext

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer von Brahmer, Julie R, Tykodi, Scott S, Chow, Laura Q.M, Hwu, Wen-Jen, Topalian, Suzanne L, Hwu, Patrick, Drake, Charles G, Camacho, Luis H, Kauh, John, Odunsi, Kunle, Pitot, Henry C, Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M, Alaparthy, Suresh, Grosso, Joseph F, Korman, Alan J, Parker, Susan M, Agrawal, Shruti, Goldberg, Stacie M, Pardoll, Drew M, Gupta, Ashok, Wigginton, Jon M

Volltext

T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-γ von Moon, Hyung-Geun, Yu, Qing, Du, Hansen, Waterman, Marian L, Sharma, Archna, Salay, Theresa M, Leeds, Karen E, Wu, Beibei, Zhu, Zhou, Oh, Sun Young, Sen, Jyoti Misra, Hossain, M Zulfiquer

Volltext

Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4 + T Cells von Li, Yili, Depontieu, Florence R., Sidney, John, Salay, Theresa M., Engelhard, Victor H., Hunt, Donald F., Sette, Alessandro, Topalian, Suzanne L., Mariuzza, Roy A.

Volltext

T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-[gamma] von Yu, Qing, Sharma, Archna, Oh, Sun Young, Moon, Hyung-geun, Hossain, M Zulfiquer, Salay, Theresa M, Leeds, Karen E, Du, Hansen, Wu, Beibei, Waterman, Marian L, Zhu, Zhou, Sen, Jyoti Misra

Volltext

Safety and immunologic correlates of allogeneic melanoma GVAX (MelGVAX), a genetically engineered whole-cell melanoma vaccine von Lipson, Evan J., Sharfman, William Howard, Chen, Shuming, McMiller, Tracee L., Pritchard, Theresa Salay, Salas, January T., Sartorius-Mergenthaler, Susan, Ravi, Sowmya, Wang, Hao, Taube, Janis M., Pardoll, Drew M., Topalian, Suzanne Louise

Volltext